ConductScience.org, home

Paper38201655

Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas.

Li X and 10 others. Cancers (Basel), 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas. Papers, record 38201655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38201655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.95, provisional
iCite
Revised in PubMed
2024-01-14
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXiaoouhttps://orcid.org/0009-0009-1548-4902
2Xiao XXiong
3Wang YYi
4Gu GGuocanhttps://orcid.org/0009-0006-2526-3474
5Li TTian
6Wang YYi
7Li CChunzhaohttps://orcid.org/0000-0002-9983-3779
8Zhang PPeng
9Ji NNanhttps://orcid.org/0000-0002-9001-8858
10Zhang YYang
11Zhang LLiwei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JingYiYan 2018-7Beijing Municipal Special Funds for Medical ResearchPubMed

Source PubMed

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132098194Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells.Cancers (Basel)2020https://conductscience.org/library/papers/32098194PubMed
232464096The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.Cell Stem Cell2020https://conductscience.org/library/papers/32464096PubMed
335570396Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors.Mol Ther2022https://conductscience.org/library/papers/35570396PubMed
427157264Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets.Curr Neuropharmacol2017https://conductscience.org/library/papers/27157264PubMed
523512689Brainstem glioma: a review.Curr Neurol Neurosci Rep2013https://conductscience.org/library/papers/23512689PubMed
620400066Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastoma U251 cells.Cell Immunol2010https://conductscience.org/library/papers/20400066PubMed
717172420Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.Mol Cancer Ther2006https://conductscience.org/library/papers/17172420PubMed
815870068Characterization of the interaction between interleukin-13 and interleukin-13 receptors.J Biol Chem2005https://conductscience.org/library/papers/15870068PubMed
922424217Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele.Cytotherapy2012https://conductscience.org/library/papers/22424217PubMed
1018590440Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.J Neurosurg2008https://conductscience.org/library/papers/18590440PubMed
1119276162Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model.Mol Cancer Ther2009https://conductscience.org/library/papers/19276162PubMed
1228029927Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.N Engl J Med2016https://conductscience.org/library/papers/28029927PubMed
1329203539Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.J Exp Med2018https://conductscience.org/library/papers/29203539PubMed
1437999129Surgical Management of Adult Brainstem Gliomas: A Systematic Review and Meta-Analysis.Curr Oncol2023https://conductscience.org/library/papers/37999129PubMed
1518566228Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.Mol Cancer Ther2008https://conductscience.org/library/papers/18566228PubMed
1621030678Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/21030678PubMed
1716314943Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.J Neurooncol2006https://conductscience.org/library/papers/16314943PubMed
1821946118An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts.Neuro Oncol2012https://conductscience.org/library/papers/21946118PubMed
1933398531Brain stem gliomas and current landscape.J Neurooncol2021https://conductscience.org/library/papers/33398531PubMed
2037358632A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.Neurosurg Rev2023https://conductscience.org/library/papers/37358632PubMed

See all 62 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42043033Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review.Toxins (Basel)2026https://conductscience.org/library/papers/42043033PubMed
41540212Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma.Commun Biol2026https://conductscience.org/library/papers/41540212PubMed
40678065Spatial transcriptomic analysis of 4NQO-induced tongue cancer revealed cellular lineage diversity and evolutionary trajectory.Front Oncol2025https://conductscience.org/library/papers/40678065PubMed
40663259Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling.Clin Exp Metastasis2025https://conductscience.org/library/papers/40663259PubMed
39991094Big data for neuroscience in the context of predictive, preventive, and personalized medicine.EPMA J2025https://conductscience.org/library/papers/39991094PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38201655

GET https://conductscience.org/api/papers/v1/38201655/references?page=2